Analysen von Emmanuel Papadakis

06.12.19 Sanofi Underweight Barclays Capital
25.10.19 Novartis Underweight Barclays Capital
05.09.19 Novartis Underweight Barclays Capital
19.07.19 Novartis Underweight Barclays Capital
17.05.19 Novo Nordisk Underweight Barclays Capital
06.05.19 Novo Nordisk Underweight Barclays Capital
10.04.19 Novartis Underweight Barclays Capital
08.04.19 Novartis Underweight Barclays Capital
08.04.19 Merck Underweight Barclays Capital
05.02.19 Novo Nordisk verkaufen Barclays Capital
01.02.19 Novartis Underweight Barclays Capital
16.01.19 Novartis Underweight Barclays Capital
15.01.19 Merck Underweight Barclays Capital
10.12.18 Novartis Underweight Barclays Capital
08.12.18 Novartis Underweight Barclays Capital
15.10.18 Sanofi Underweight Barclays Capital
09.10.18 Merck Underweight Barclays Capital
13.08.18 Novo Nordisk Underweight Barclays Capital
01.08.18 Sanofi Underweight Barclays Capital
25.06.18 Sanofi Underweight Barclays Capital
25.06.18 Novartis Underweight Barclays Capital
22.06.18 Novo Nordisk Underweight Barclays Capital
18.06.18 Novartis Underweight Barclays Capital
22.05.18 Novartis Underweight Barclays Capital
30.04.18 Bayer Underweight Barclays Capital
30.04.18 Sanofi Underweight Barclays Capital
20.04.18 Novartis Underweight Barclays Capital
12.04.18 Bayer Underweight Barclays Capital
11.04.18 Novartis Underweight Barclays Capital
09.03.18 Bayer Underweight Barclays Capital
08.03.18 Novo Nordisk Underweight Barclays Capital
05.03.18 Bayer Underweight Barclays Capital
20.02.18 Novartis Underweight Barclays Capital
20.02.18 Sanofi Underweight Barclays Capital
25.01.18 Novartis Underweight Barclays Capital
23.01.18 Sanofi Underweight Barclays Capital
22.01.18 Bayer Underweight Barclays Capital
03.01.18 Bayer Underweight Barclays Capital
06.12.17 Bayer Underweight Barclays Capital
17.11.17 Bayer Underweight Barclays Capital
15.11.17 Novo Nordisk Underweight Barclays Capital
07.11.17 Bayer Underweight Barclays Capital
06.11.17 Bayer Underweight Barclays Capital
25.10.17 Novartis Underweight Barclays Capital
10.08.17 Novo Nordisk Underweight Barclays Capital
02.06.17 Novartis Underweight Barclays Capital
08.05.17 Sanofi Underweight Barclays Capital
08.03.17 Novo Nordisk Underweight Barclays Capital
08.03.17 Sanofi Underweight Barclays Capital